Clinical Trial

CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The investigators conduct a prospective, multicenter diagnostic trial primarily aimed at evaluating the value of contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) in differentiating gastrointestinal stromal tumors (GISTs) from leiomyomas, as well as its predictive utility in the risk stratification of GISTs.
Trial Details
NCT Number NCT07106411
Lead Sponsor Huazhong University of Science and Technology
Collaborators: Zhongnan Hospital, Wuhan Central Hospital
Conditions Submucosal Tumor, Gastrointestinal Stromal Tumor (GIST), Leiomyoma
Enrollment 288 participants
Start Date 2025-08
Primary Completion 2026-06 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-06